Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

TR1 Notification

2 Jun 2023 16:48

RNS Number : 5535B
Ergomed plc
02 June 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7ZCY67

Issuer Name

ERGOMED PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Octopus Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

England

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

01-Jun-2023

6. Date on which Issuer notified

02-Jun-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

12.030000

0.000000

12.030000

6110199

Position of previous notification (if applicable)

11.530000

0.000000

11.530000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7ZCY67

6110199

12.030000

Sub Total 8.A

6110199

12.030000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Octopus Capital Limited

Octopus Investments Limited

12.030000

12.030000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

02-Jun-2023

13. Place Of Completion

33 Holborn, London, EC1N 2HT

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDZGGVKZVGFZM
Date   Source Headline
2nd Apr 20207:00 amRNSUpdate on Siltuximab Clinical Study
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20204:36 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSErgomed’s PrimeVigilance Supports COVID-19 Trial
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202012:44 pmEQSEdison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
25th Mar 20207:00 amRNSAudited full year results
18th Mar 20208:39 amRNSErgomed Announces COVID-19 Clinical Study
4th Mar 20207:00 amRNSNotice of Preliminary Results
2nd Mar 20207:00 amRNSTotal Voting Rights
18th Feb 20203:19 pmRNSHoldings in Company
14th Feb 20207:00 amRNSDirector/PDMR Shareholding
7th Feb 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Feb 20205:45 pmRNSHoldings in Company
30th Jan 20207:00 amRNSAward of Share Options
30th Jan 20207:00 amRNSExercise of Share Options and Total Voting Rights
29th Jan 20207:00 amRNS2019 Trading Update
20th Jan 20204:13 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSCOO, Lewis Cameron, joins Ergomed
17th Jan 20207:00 amRNSExercise of Options
13th Jan 20207:00 amRNSAcquisition of Ashfield Pharmacovigilance Inc.
2nd Jan 20207:00 amRNSTotal Voting Rights & Block Listing Return
19th Dec 201911:59 amRNSBlock Listing Application
2nd Dec 20197:00 amRNSAppointment of Chief Operating Officer
2nd Dec 20197:00 amRNSTotal Voting Rights
19th Nov 201910:30 amRNSHolding(s) in Company
14th Nov 20195:24 pmRNSHolding(s) in Company
8th Nov 20193:43 pmRNSHolding(s) in Company
8th Nov 20193:41 pmRNSHolding(s) in Company
7th Nov 20197:00 amRNSDirector's Dealing
1st Nov 20194:41 pmRNSSecond Price Monitoring Extn
1st Nov 20194:35 pmRNSPrice Monitoring Extension
1st Nov 20197:00 amRNSTotal Voting Rights
1st Oct 20197:00 amRNSTotal Voting Rights
25th Sep 20197:00 amRNSBoard Change
25th Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSBoard Change
2nd Sep 20197:00 amRNSTotal Voting Rights
29th Aug 20197:00 amRNSNotice of Interim Results
20th Aug 20197:00 amRNSBoard Appointment
1st Aug 20197:00 amRNSTotal Voting Rights
26th Jul 20193:30 pmRNSHolding(s) in Company
24th Jul 20198:04 amRNSDirector/PDMR Shareholding
23rd Jul 20193:19 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSBoard Appointments
22nd Jul 20197:00 amRNSErgomed H1 2019 Trading Update
19th Jul 20197:05 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSHoldings in Company
10th Jul 20197:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.